Mark Magdi Awad

39PUBLICATIONS
445CO-AUTHORS
Predictive and prognostic markersMolecular targetsHaematological tumoursInnate immunityCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (39)

|Jul 14, 2026
Clinical significance of EGFR amplification in patients with EGFR-mutated metastatic non-small cell lung cancer receiving first-line osimertinib.

|Jun 22, 2026
EML4-ALK mediates resistance to KRAS G12C inhibition and induces an oncogenic dependency by rewiring signaling through the wild-type RAS pathway.

|May 18, 2026
Clinical outcomes and predictors of response to PD-(L)1 blockade in patients with NSCLC without actionable genomic alterations who never used tobacco.

|May 05, 2026
Metastatic Trajectories in Non-Small Cell Lung Cancer Guide Local and Systemic Therapies.

|Feb 23, 2026
Evolution of oncogene amplification across 86,000 cancer cell genomes.

Jake June-Koo Lee, Sohrab Salehi, Matthew A Myers

|Feb 04, 2026
Kras G12C- and G12D-driven lung cancers differ in oncogenic potency, immunogenicity, and relapse after Kras inhibition in mouse models.

Hai-Cheng Huang, Qing Deng, Lei Guo

Pageof 7

Frequent Collaborators

26 joint publications

Biagio Ricciuti

19 joint publications

Joao Victor Alessi

13 joint publications

Alessandro Di Federico

11 joint publications

Lynette Sholl